10x Genomics, Inc. Overview
Pro stress-test →10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. The integrated research solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology.
Strategic Profile
Pro stress-test →The company is expanding impact of its platforms, driven by new product innovations and strategic partnerships, well positioned to execute across multiple growth vectors in the business, especially AI-driven demand, translational research and emerging clinical opportunities. The company maintains a robust gross margin of 68.84%, indicating efficient production processes.
Competitive Landscape
Pro stress-test →10x Genomics holds vibrant adoption rates of new technologies bolstering its position in the competitive genomics sector. Primary competitors include Pacific Biosciences (PACB), Parse Biosciences, and other single-cell sequencing platforms. The company's differentiation lies in its integrated portfolio combining instruments, consumables, and software with expanding AI and clinical partnerships.
Industry Context
10x Genomics, Inc. operates in Life Sciences Equipment & Services / Genomics Technology.
Key facts
Founded: 2012 · Headquarters: Pleasanton, US · Revenue: $642.8M (2025) · Market cap: $2.22B